Hey Kitty, this is my first post on Yahoo! MB. I have been a lurker here since I bought in to TSRX in December. Do you have an opinion on NAVB? I have a small position with them and am thinking about buying more. Their key product Lymphoseek is the 1st lymph node mapping diagnostic approved by the FDA in 30 years and is highly accurate- it got FDA approval in March for 2x types of cancer and passed phase 3 with flying colors yesterday for 2x other types of cancer. They are partnered with Cardinal for sales & marketing of this product and sales are expected 2Q of this year (basically, starting now).
Is this on your radar? What is your opinion? Thanks,
Longer term it may be OK, I had some for trading, kind of did a belly flop on approval. Maybe a good entry now with other catalysts looming. I don't really have a handle on how well their sales and earnings will ramp or how long that will take. That is why I say longer term it MAY be OK or more likely maybe a good entry for a swing trade from here to $3's. You can decide how you want to handle it for your goals.